XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer

Lead

Harbin Medical University

With

• Cancer Institute and Hospital, Chinese Academy of Medical Sciences
• Fudan University
• Sun Yat-sen University
• First Affiliated Hospital of Harbin Medical University
• The Second Affiliated Hospital of Harbin Medical University
• Liaoning Cancer Hospital & Institute
• Shengjing Hospital
• The First Hospital of Jilin University
• The First Affiliated Hospital of Dalian Medical University
• Jilin Provincial Tumor Hospital
• Jinzhou Medical University